|
1
|
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
|
J Clin Oncol
|
2006
|
5.78
|
|
2
|
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
|
Nat Genet
|
2011
|
4.38
|
|
3
|
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
|
J Clin Oncol
|
2008
|
3.51
|
|
4
|
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.
|
Ann Surg
|
2009
|
3.15
|
|
5
|
Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.
|
Hepatology
|
2014
|
2.98
|
|
6
|
Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.
|
Ann Surg Oncol
|
2006
|
2.66
|
|
7
|
Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors.
|
J Am Coll Surg
|
2012
|
2.29
|
|
8
|
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis.
|
Ann Surg Oncol
|
2007
|
2.26
|
|
9
|
Intrahepatic cholangiocarcinoma: management options and emerging therapies.
|
J Am Coll Surg
|
2013
|
2.22
|
|
10
|
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
|
J Clin Oncol
|
2011
|
2.13
|
|
11
|
Solitary colorectal liver metastasis: resection determines outcome.
|
Arch Surg
|
2006
|
2.06
|
|
12
|
Limitations of claims and registry data in surgical oncology research.
|
Ann Surg Oncol
|
2007
|
2.06
|
|
13
|
Is extended hepatectomy for hepatobiliary malignancy justified?
|
Ann Surg
|
2004
|
2.01
|
|
14
|
Pancreatic resection of isolated metastases from nonpancreatic primary cancers.
|
Ann Surg Oncol
|
2008
|
1.97
|
|
15
|
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.
|
Cancer
|
2013
|
1.94
|
|
16
|
Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
|
Ann Surg Oncol
|
2007
|
1.94
|
|
17
|
Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis.
|
J Gastrointest Surg
|
2007
|
1.87
|
|
18
|
Predictors of survival after resection of early hepatocellular carcinoma.
|
Ann Surg
|
2009
|
1.85
|
|
19
|
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.
|
HPB (Oxford)
|
2011
|
1.82
|
|
20
|
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
|
Ann Surg Oncol
|
2010
|
1.79
|
|
21
|
Biology of hepatocellular carcinoma.
|
Ann Surg Oncol
|
2008
|
1.78
|
|
22
|
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
|
Ann Surg
|
2014
|
1.76
|
|
23
|
Operative mortality after hepatic resection: are literature-based rates broadly applicable?
|
J Gastrointest Surg
|
2008
|
1.69
|
|
24
|
Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
|
Ann Surg
|
2009
|
1.68
|
|
25
|
Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series.
|
J Am Coll Surg
|
2009
|
1.67
|
|
26
|
Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.
|
Radiology
|
2013
|
1.66
|
|
27
|
A proposed staging system for intrahepatic cholangiocarcinoma.
|
Ann Surg Oncol
|
2008
|
1.64
|
|
28
|
Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.
|
J Gastrointest Surg
|
2012
|
1.64
|
|
29
|
Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy.
|
J Am Coll Surg
|
2011
|
1.64
|
|
30
|
Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas.
|
Ann Surg Oncol
|
2010
|
1.60
|
|
31
|
Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system.
|
Arch Surg
|
2011
|
1.59
|
|
32
|
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.
|
HPB (Oxford)
|
2010
|
1.59
|
|
33
|
Informed consent and the surgeon.
|
J Am Coll Surg
|
2009
|
1.58
|
|
34
|
The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma.
|
Ann Surg Oncol
|
2014
|
1.58
|
|
35
|
Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.
|
Ann Surg
|
2010
|
1.56
|
|
36
|
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
|
Cancer
|
2014
|
1.55
|
|
37
|
Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.
|
J Am Coll Surg
|
2012
|
1.55
|
|
38
|
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.
|
Ann Surg Oncol
|
2005
|
1.53
|
|
39
|
Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
|
Ann Surg Oncol
|
2014
|
1.53
|
|
40
|
The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship.
|
J Am Coll Surg
|
2009
|
1.52
|
|
41
|
Improving surgical outcomes through adoption of evidence-based process measures: intervention specific or associated with overall hospital quality?
|
Surgery
|
2009
|
1.51
|
|
42
|
Selection for hepatic resection of colorectal liver metastases: expert consensus statement.
|
HPB (Oxford)
|
2013
|
1.50
|
|
43
|
Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making.
|
Ann Surg Oncol
|
2012
|
1.50
|
|
44
|
Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis.
|
Ann Surg Oncol
|
2010
|
1.50
|
|
45
|
Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP.
|
Ann Surg
|
2013
|
1.45
|
|
46
|
A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer.
|
HPB (Oxford)
|
2012
|
1.45
|
|
47
|
ACS-NSQIP has the potential to create an HPB-NSQIP option.
|
HPB (Oxford)
|
2009
|
1.44
|
|
48
|
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.
|
Ann Surg Oncol
|
2009
|
1.44
|
|
49
|
Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients.
|
Ann Surg Oncol
|
2012
|
1.44
|
|
50
|
Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion.
|
HPB (Oxford)
|
2011
|
1.44
|
|
51
|
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.
|
Cancer
|
2011
|
1.43
|
|
52
|
Evolving treatment strategies for gallbladder cancer.
|
Ann Surg Oncol
|
2009
|
1.42
|
|
53
|
Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis.
|
World J Surg
|
2015
|
1.42
|
|
54
|
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.
|
J Gastrointest Surg
|
2009
|
1.41
|
|
55
|
Trends in the quality of highly cited surgical research over the past 20 years.
|
Ann Surg
|
2009
|
1.41
|
|
56
|
Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients.
|
J Am Coll Surg
|
2010
|
1.37
|
|
57
|
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.
|
J Gastrointest Surg
|
2010
|
1.36
|
|
58
|
Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.
|
J Gastrointest Surg
|
2010
|
1.33
|
|
59
|
Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
|
Arch Surg
|
2008
|
1.32
|
|
60
|
Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.
|
Ann Surg Oncol
|
2011
|
1.31
|
|
61
|
Choledochal cyst disease in children and adults: a 30-year single-institution experience.
|
J Am Coll Surg
|
2008
|
1.29
|
|
62
|
Intrahepatic cholangiocarcinoma.
|
Surg Clin North Am
|
2010
|
1.27
|
|
63
|
Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.
|
J Gastrointest Surg
|
2007
|
1.26
|
|
64
|
A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma.
|
J Am Coll Surg
|
2012
|
1.26
|
|
65
|
Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
|
Ann Surg Oncol
|
2011
|
1.24
|
|
66
|
Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience.
|
J Gastrointest Surg
|
2008
|
1.23
|
|
67
|
Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio.
|
J Gastrointest Surg
|
2008
|
1.22
|
|
68
|
Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
|
Ann Surg
|
2009
|
1.22
|
|
69
|
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.
|
J Clin Oncol
|
2013
|
1.22
|
|
70
|
MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.
|
Hepatology
|
2011
|
1.22
|
|
71
|
Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.
|
J Gastrointest Surg
|
2006
|
1.22
|
|
72
|
Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital?
|
J Gastrointest Surg
|
2010
|
1.20
|
|
73
|
Volume-based trends in thyroid surgery.
|
Arch Otolaryngol Head Neck Surg
|
2010
|
1.19
|
|
74
|
Disappearing colorectal liver metastases after chemotherapy: should we be concerned?
|
J Gastrointest Surg
|
2010
|
1.19
|
|
75
|
Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis.
|
Surgery
|
2011
|
1.17
|
|
76
|
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
|
Cancer
|
2012
|
1.16
|
|
77
|
Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma?
|
J Am Coll Surg
|
2013
|
1.16
|
|
78
|
Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis.
|
Ann Surg Oncol
|
2010
|
1.16
|
|
79
|
Risk of morbidity and mortality following hepato-pancreato-biliary surgery.
|
J Gastrointest Surg
|
2012
|
1.16
|
|
80
|
Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis.
|
J Am Coll Surg
|
2012
|
1.14
|
|
81
|
Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis.
|
J Am Coll Surg
|
2013
|
1.14
|
|
82
|
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients.
|
Hum Pathol
|
2009
|
1.13
|
|
83
|
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.
|
Gastrointest Cancer Res
|
2013
|
1.13
|
|
84
|
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis.
|
Ann Surg
|
2010
|
1.13
|
|
85
|
Malignant transformation of hepatic adenomas.
|
Mod Pathol
|
2008
|
1.13
|
|
86
|
Current management of colorectal hepatic metastasis.
|
Expert Rev Gastroenterol Hepatol
|
2009
|
1.12
|
|
87
|
Understanding surgical decision making in early hepatocellular carcinoma.
|
J Clin Oncol
|
2011
|
1.12
|
|
88
|
Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.
|
Surgery
|
2009
|
1.11
|
|
89
|
Infiltrating hepatocellular carcinoma: seeing the tree through the forest.
|
J Gastrointest Surg
|
2011
|
1.11
|
|
90
|
Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes.
|
Ann Surg Oncol
|
2012
|
1.11
|
|
91
|
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
|
JAMA Surg
|
2014
|
1.11
|
|
92
|
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
|
Radiat Oncol
|
2011
|
1.10
|
|
93
|
Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study.
|
J Gastrointest Surg
|
2010
|
1.10
|
|
94
|
Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
|
Cancer
|
2007
|
1.08
|
|
95
|
Multidisciplinary approaches to intrahepatic cholangiocarcinoma.
|
Cancer
|
2013
|
1.08
|
|
96
|
Risk factors for pancreatic leak after distal pancreatectomy.
|
Ann Surg
|
2009
|
1.08
|
|
97
|
Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
|
Ann Surg Oncol
|
2009
|
1.07
|
|
98
|
Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival.
|
J Gastrointest Surg
|
2011
|
1.07
|
|
99
|
Surgical management of hepatic hemangiomas: a multi-institutional experience.
|
HPB (Oxford)
|
2014
|
1.05
|
|
100
|
Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
|
Ann Surg Oncol
|
2013
|
1.05
|
|
101
|
The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography.
|
Arch Surg
|
2010
|
1.05
|
|
102
|
Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
|
Ann Surg
|
2013
|
1.04
|
|
103
|
Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?
|
J Gastrointest Surg
|
2008
|
1.04
|
|
104
|
Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective.
|
J Surg Oncol
|
2009
|
1.04
|
|
105
|
National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.
|
Cancer
|
2011
|
1.04
|
|
106
|
Two-stage strategy for patients with extensive bilateral colorectal liver metastases.
|
HPB (Oxford)
|
2010
|
1.04
|
|
107
|
Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria.
|
Radiology
|
2013
|
1.03
|
|
108
|
Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.
|
J Clin Invest
|
2002
|
1.03
|
|
109
|
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.
|
Ann Surg Oncol
|
2014
|
1.02
|
|
110
|
Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
|
Cancer
|
2011
|
1.02
|
|
111
|
Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.
|
J Am Coll Surg
|
2013
|
1.02
|
|
112
|
Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.
|
J Gastrointest Surg
|
2013
|
1.01
|
|
113
|
Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.
|
Radiology
|
2012
|
1.01
|
|
114
|
Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.
|
Dis Colon Rectum
|
2012
|
1.00
|
|
115
|
Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
|
Ann Surg
|
2015
|
0.99
|
|
116
|
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
|
Ann Surg Oncol
|
2008
|
0.99
|
|
117
|
Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?
|
J Am Coll Surg
|
2013
|
0.99
|
|
118
|
2564 resected periampullary adenocarcinomas at a single institution: trends over three decades.
|
HPB (Oxford)
|
2013
|
0.99
|
|
119
|
Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome.
|
HPB (Oxford)
|
2010
|
0.99
|
|
120
|
Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma.
|
J Surg Oncol
|
2011
|
0.99
|
|
121
|
Body mass index and adverse perioperative outcomes following hepatic resection.
|
J Gastrointest Surg
|
2010
|
0.98
|
|
122
|
Palliation of hepatic tumors.
|
Surg Oncol
|
2007
|
0.98
|
|
123
|
Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
|
Ann Surg
|
2015
|
0.98
|
|
124
|
Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival.
|
Radiology
|
2012
|
0.98
|
|
125
|
Management of perihilar cholangiocarcinoma in the era of multimodal therapy.
|
Expert Rev Gastroenterol Hepatol
|
2012
|
0.97
|
|
126
|
Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis.
|
Surgery
|
2012
|
0.97
|
|
127
|
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
|
Ann Surg Oncol
|
2015
|
0.97
|
|
128
|
Survival benefit of liver transplantation and the effect of underlying liver disease.
|
Surgery
|
2009
|
0.97
|
|
129
|
Recurrence after operative management of intrahepatic cholangiocarcinoma.
|
Surgery
|
2013
|
0.96
|
|
130
|
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer.
|
J Gastrointest Surg
|
2012
|
0.96
|
|
131
|
Thermal ablative therapies for secondary hepatic malignancies.
|
Cancer J
|
2010
|
0.95
|
|
132
|
A risk model to predict 90-day mortality among patients undergoing hepatic resection.
|
J Am Coll Surg
|
2013
|
0.95
|
|
133
|
Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.
|
Radiother Oncol
|
2009
|
0.95
|
|
134
|
Disclosure of "nonharmful" medical errors and other events: duty to disclose.
|
Arch Surg
|
2012
|
0.95
|
|
135
|
Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative.
|
Ann Surg Oncol
|
2014
|
0.95
|
|
136
|
Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors.
|
J Gastrointest Surg
|
2014
|
0.94
|
|
137
|
Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor.
|
Ann Surg
|
2015
|
0.94
|
|
138
|
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years.
|
Cancer
|
2014
|
0.94
|
|
139
|
Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies.
|
J Gastrointest Surg
|
2013
|
0.94
|
|
140
|
Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomy.
|
Surgery
|
2013
|
0.94
|
|
141
|
Making unresectable hepatic colorectal metastases resectable--does it work?
|
Semin Oncol
|
2005
|
0.94
|
|
142
|
Early versus late readmission after surgery among patients with employer-provided health insurance.
|
Ann Surg
|
2015
|
0.94
|
|
143
|
Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.
|
Pract Radiat Oncol
|
2012
|
0.94
|
|
144
|
Regulation of herpes simplex virus 1 replication using tumor-associated promoters.
|
Ann Surg
|
2002
|
0.93
|
|
145
|
Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia.
|
J Gastrointest Surg
|
2015
|
0.93
|
|
146
|
Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis.
|
Ann Surg Oncol
|
2012
|
0.93
|
|
147
|
Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more.
|
Ann Surg Oncol
|
2009
|
0.93
|
|
148
|
Treatment options and surveillance strategies after therapy for hepatocellular carcinoma.
|
Ann Surg Oncol
|
2013
|
0.93
|
|
149
|
Colorectal liver metastases.
|
Int J Surg Oncol
|
2011
|
0.93
|
|
150
|
Trends in Hospital Volume and Failure to Rescue for Pancreatic Surgery.
|
J Gastrointest Surg
|
2015
|
0.93
|
|
151
|
The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome.
|
Hum Pathol
|
2013
|
0.92
|
|
152
|
Clinicopathologic features in colorectal cancer patients with microsatellite instability.
|
Mutat Res
|
2004
|
0.92
|
|
153
|
Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis.
|
J Gastrointest Surg
|
2010
|
0.92
|
|
154
|
Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch.
|
PLoS One
|
2012
|
0.92
|
|
155
|
Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection.
|
Ann Surg Oncol
|
2011
|
0.92
|
|
156
|
Cadmium exposure and liver disease among US adults.
|
J Gastrointest Surg
|
2013
|
0.92
|
|
157
|
Enhanced recovery after surgery protocols for open hepatectomy--physiology, immunomodulation, and implementation.
|
J Gastrointest Surg
|
2014
|
0.92
|
|
158
|
Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation.
|
HPB (Oxford)
|
2010
|
0.92
|
|
159
|
Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows.
|
Updates Surg
|
2010
|
0.91
|
|
160
|
Racial disparity in surgical mortality after major hepatectomy.
|
J Am Coll Surg
|
2008
|
0.91
|
|
161
|
Advances in understanding of colorectal liver metastasis and implications for the clinic.
|
Expert Rev Gastroenterol Hepatol
|
2014
|
0.91
|
|
162
|
Training in Hepatopancreatobiliary Surgery: Assessment of the Hepatopancreatobiliary Surgery Workforce in North America.
|
Ann Surg
|
2015
|
0.91
|
|
163
|
Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA.
|
J Gastrointest Surg
|
2013
|
0.91
|
|
164
|
Staging of intrahepatic cholangiocarcinoma.
|
Curr Opin Gastroenterol
|
2010
|
0.90
|
|
165
|
Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site.
|
Arch Surg
|
2008
|
0.90
|
|
166
|
A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancer.
|
Transl Oncol
|
2010
|
0.90
|
|
167
|
Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma.
|
Ann Surg Oncol
|
2012
|
0.89
|
|
168
|
A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
|
Ann Surg Oncol
|
2014
|
0.89
|
|
169
|
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.89
|
|
170
|
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience.
|
J Gastrointest Surg
|
2011
|
0.89
|
|
171
|
Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era.
|
Ann Surg Oncol
|
2010
|
0.89
|
|
172
|
Surgical management of noncolorectal cancer liver metastases.
|
Cancer
|
2014
|
0.88
|
|
173
|
Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis.
|
BMC Health Serv Res
|
2012
|
0.88
|
|
174
|
ACR Appropriateness Criteria® Resectable Stomach Cancer.
|
Oncology (Williston Park)
|
2015
|
0.88
|
|
175
|
Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.
|
J Gastrointest Surg
|
2014
|
0.88
|
|
176
|
Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.88
|
|
177
|
Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases.
|
Arch Surg
|
2008
|
0.88
|
|
178
|
Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma.
|
J Gastrointest Surg
|
2014
|
0.88
|
|
179
|
Readmission incidence and associated factors after a hepatic resection at a major hepato-pancreatico-biliary academic centre.
|
HPB (Oxford)
|
2014
|
0.87
|
|
180
|
Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.87
|
|
181
|
Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes.
|
Ann Surg Oncol
|
2014
|
0.87
|
|
182
|
Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.
|
PLoS One
|
2013
|
0.87
|
|
183
|
Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.
|
Cancer
|
2004
|
0.87
|
|
184
|
Variations in surgical outcomes associated with hospital compliance with safety practices.
|
Surgery
|
2012
|
0.87
|
|
185
|
Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.
|
Cardiovasc Intervent Radiol
|
2012
|
0.86
|
|
186
|
Assessing short- and long-term outcomes among black vs white Medicare patients undergoing resection of colorectal cancer.
|
Am J Surg
|
2013
|
0.86
|
|
187
|
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.86
|
|
188
|
Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases.
|
Surgery
|
2013
|
0.86
|
|
189
|
Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen.
|
Cancer Res
|
2004
|
0.86
|
|
190
|
Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges?
|
Ann Surg Oncol
|
2009
|
0.86
|
|
191
|
Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension.
|
World J Surg Oncol
|
2008
|
0.86
|
|
192
|
Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis.
|
Surgery
|
2012
|
0.86
|
|
193
|
Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis.
|
J Surg Oncol
|
2010
|
0.86
|
|
194
|
A comparison of right posterior sectorectomy with formal right hepatectomy: a dual-institution study.
|
HPB (Oxford)
|
2013
|
0.85
|
|
195
|
Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?
|
J Surg Oncol
|
2011
|
0.85
|
|
196
|
Resection of non-hepatic colorectal cancer metastasis.
|
J Gastrointest Oncol
|
2012
|
0.85
|
|
197
|
Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
|
Arch Surg
|
2011
|
0.85
|
|
198
|
Trends and risk factors for transfusion in hepatopancreatobiliary surgery.
|
J Gastrointest Surg
|
2013
|
0.84
|
|
199
|
Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study.
|
J Surg Oncol
|
2014
|
0.84
|
|
200
|
The Orphan Drug Act: Restoring the Mission to Rare Diseases.
|
Am J Clin Oncol
|
2016
|
0.84
|
|
201
|
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
|
Cancer
|
2012
|
0.84
|
|
202
|
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
|
AJR Am J Roentgenol
|
2015
|
0.84
|
|
203
|
Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration.
|
Ann Surg Oncol
|
2014
|
0.84
|
|
204
|
What are patients' expectations about the effects of chemotherapy for advanced cancer?
|
J Am Coll Surg
|
2014
|
0.84
|
|
205
|
Intraoperative surgical margin re-resection for colorectal liver metastasis: is it worth the effort?
|
J Gastrointest Surg
|
2014
|
0.84
|
|
206
|
Management of large hepatocellular carcinoma in adult patients with Alagille syndrome: a case report and review of literature.
|
Dig Dis Sci
|
2010
|
0.84
|
|
207
|
Echogenic appearance of colorectal liver metastases on intraoperative ultrasonography is associated with survival after hepatic resection.
|
J Gastrointest Surg
|
2007
|
0.83
|
|
208
|
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.
|
J Clin Oncol
|
2005
|
0.83
|
|
209
|
Choosing a cancer surgeon: analyzing factors in patient decision making using a best-worst scaling methodology.
|
Ann Surg Oncol
|
2014
|
0.83
|
|
210
|
Accuracy of marketing claims by providers of stereotactic radiation therapy.
|
J Oncol Pract
|
2013
|
0.83
|
|
211
|
Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.
|
J Gastrointest Surg
|
2013
|
0.83
|
|
212
|
Functional MR imaging as a new paradigm for image guidance.
|
Abdom Imaging
|
2008
|
0.83
|
|
213
|
Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery.
|
J Gastrointest Surg
|
2015
|
0.83
|
|
214
|
Stereotactic body radiation therapy planning with duodenal sparing using volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: a dosimetric analysis.
|
Med Dosim
|
2013
|
0.82
|
|
215
|
Spirituality and religion in the care of surgical oncology patients with life-threatening or advanced illnesses.
|
Ann Surg Oncol
|
2008
|
0.82
|
|
216
|
Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.
|
Eur Radiol
|
2014
|
0.82
|
|
217
|
Unnecessary tests and procedures in patients presenting with solid tumors of the pancreas.
|
J Gastrointest Surg
|
2013
|
0.82
|
|
218
|
Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?
|
J Gastrointest Surg
|
2014
|
0.82
|
|
219
|
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma.
|
World J Surg
|
2011
|
0.82
|
|
220
|
Surgical management and emerging therapies to prolong survival in metastatic neuroendocrine cancer.
|
Ann Surg Oncol
|
2010
|
0.82
|
|
221
|
Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges.
|
HPB (Oxford)
|
2014
|
0.82
|
|
222
|
Defining incidence and risk factors of venous thromboemolism after hepatectomy.
|
J Gastrointest Surg
|
2013
|
0.82
|
|
223
|
Surgical Management of Intrahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema.
|
Ann Surg Oncol
|
2015
|
0.81
|
|
224
|
Doing more: trends in breast cancer surgery, 2005 to 2011.
|
Am Surg
|
2015
|
0.81
|
|
225
|
Anatomical Resections Improve Disease-Free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
|
Ann Surg
|
2017
|
0.81
|
|
226
|
Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma.
|
J Surg Oncol
|
2012
|
0.81
|
|
227
|
Local therapies for hepatic metastases.
|
J Natl Compr Canc Netw
|
2013
|
0.81
|
|
228
|
Comparative performances of staging systems for early hepatocellular carcinoma.
|
HPB (Oxford)
|
2009
|
0.81
|
|
229
|
Infected primary retroperitoneal teratoma presenting as a subhepatic abscess in a postpartum woman.
|
Am J Surg
|
2010
|
0.81
|
|
230
|
Technology-assisted versus clamp-crush liver resection: a systematic review and meta-analysis.
|
Surg Innov
|
2012
|
0.81
|
|
231
|
Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis.
|
J Surg Oncol
|
2014
|
0.81
|
|
232
|
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
|
J Gastrointest Oncol
|
2013
|
0.81
|
|
233
|
Primary sclerosing cholangitis: the role of extrahepatic biliary resection.
|
Adv Surg
|
2009
|
0.81
|
|
234
|
Hereditary pancreatic and hepatobiliary cancers.
|
Int J Surg Oncol
|
2011
|
0.81
|
|
235
|
IMPROVING SAFE PATIENT THROUGHPUT IN A MULTIDISCIPLINARY ONCOLOGY CLINIC.
|
Physician Leadersh J
|
2015
|
0.81
|
|
236
|
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.
|
Radiother Oncol
|
2012
|
0.81
|
|
237
|
Readmission after surgery.
|
Adv Surg
|
2014
|
0.81
|
|
238
|
Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.
|
J Gastrointest Surg
|
2015
|
0.81
|
|
239
|
Pancreaticoduodenectomy: time to change our approach?
|
Lancet Oncol
|
2013
|
0.80
|
|
240
|
Primary biliary tract melanoma: Report of a case and review of the literature.
|
Int J Surg Case Rep
|
2012
|
0.80
|
|
241
|
Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery.
|
Surg Endosc
|
2013
|
0.80
|
|
242
|
Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival.
|
J Gastrointest Surg
|
2007
|
0.80
|
|
243
|
Young patients undergoing resection of pancreatic cancer fare better than their older counterparts.
|
J Gastrointest Surg
|
2012
|
0.80
|
|
244
|
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.80
|
|
245
|
National assessment of margin status as a quality indicator after pancreatic cancer surgery.
|
Ann Surg Oncol
|
2013
|
0.80
|
|
246
|
The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
|
World J Surg
|
2015
|
0.79
|
|
247
|
Minimally invasive resection of choledochal cyst: a feasible and safe surgical option.
|
J Gastrointest Surg
|
2014
|
0.79
|
|
248
|
Can physicians refuse treatment to patients who smoke?
|
J Oncol Pract
|
2009
|
0.79
|
|
249
|
Does relative value unit-based compensation shortchange the acute care surgeon?
|
J Trauma Acute Care Surg
|
2014
|
0.79
|
|
250
|
Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408).
|
Br J Surg
|
2004
|
0.79
|
|
251
|
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.
|
J Natl Compr Canc Netw
|
2014
|
0.79
|
|
252
|
Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US.
|
J Gastrointest Surg
|
2013
|
0.79
|
|
253
|
Survival of patients operated for colorectal liver metastases and concomitant extra-hepatic disease: external validation of a prognostic model.
|
J Surg Oncol
|
2012
|
0.79
|
|
254
|
Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems.
|
J Surg Oncol
|
2014
|
0.78
|
|
255
|
Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis.
|
J Surg Res
|
2009
|
0.78
|
|
256
|
Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey.
|
Ann Surg Oncol
|
2015
|
0.78
|
|
257
|
Intraductal papillary mucinous neoplasm of the liver: GI image.
|
J Gastrointest Surg
|
2015
|
0.78
|
|
258
|
No small issue: Hepatectomies-minimally invasive but more-than-minimally biased toward minor resections?
|
J Am Coll Surg
|
2011
|
0.78
|
|
259
|
Management of choledochal cysts.
|
Curr Opin Gastroenterol
|
2016
|
0.78
|
|
260
|
Benign solid tumors of the liver: management in the modern era.
|
J Gastrointest Surg
|
2015
|
0.78
|
|
261
|
Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.
|
Invest Radiol
|
2015
|
0.78
|
|
262
|
Liver Resection for Breast Cancer Liver Metastases: A Cost-utility Analysis.
|
Ann Surg
|
2016
|
0.78
|
|
263
|
Liver Resection for Breast Cancer Liver Metastases: A Cost-utility Analysis.
|
Ann Surg
|
2017
|
0.78
|
|
264
|
Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
265
|
Blood Transfusion Strategy and Clinical Outcomes.
|
Ann Surg
|
2015
|
0.77
|
|
266
|
Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer.
|
J Surg Oncol
|
2014
|
0.77
|
|
267
|
Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation.
|
J Gastrointest Surg
|
2012
|
0.77
|
|
268
|
Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
269
|
Age of Transfused Blood Impacts Perioperative Outcomes Among Patients Who Undergo Major Gastrointestinal Surgery.
|
Ann Surg
|
2016
|
0.77
|
|
270
|
Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis.
|
J Gastrointest Surg
|
2015
|
0.77
|
|
271
|
Ethics and the law: is there common ground on informed consent for disparities in hospital outcomes?
|
Ann Intern Med
|
2011
|
0.77
|
|
272
|
Transitoriness in cancer patients: a cross-sectional survey of lung and gastrointestinal cancer patients.
|
Support Care Cancer
|
2010
|
0.77
|
|
273
|
A nomogram to predict disease-free survival after surgical resection of GIST.
|
J Gastrointest Surg
|
2014
|
0.76
|
|
274
|
Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies.
|
HPB (Oxford)
|
2012
|
0.76
|
|
275
|
Multimodal treatment strategies for advanced hilar cholangiocarcinoma.
|
Langenbecks Arch Surg
|
2014
|
0.76
|
|
276
|
Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
|
J Magn Reson Imaging
|
2013
|
0.76
|
|
277
|
Clinical decision-making by gastroenterologists and hepatologists for patients with early hepatocellular carcinoma.
|
Ann Surg Oncol
|
2014
|
0.76
|
|
278
|
Liver transplantation for hepatocellular carcinoma: need for a new patient selection strategy.
|
Ann Surg
|
2004
|
0.76
|
|
279
|
Benefits of Bowel Preparation Beyond Surgical Site Infection: A Retrospective Study.
|
Ann Surg
|
2016
|
0.76
|
|
280
|
Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
|
Eur J Surg Oncol
|
2005
|
0.75
|
|
281
|
Supernumerary intravagal parathyroid hyperplasia.
|
Surgery
|
2002
|
0.75
|
|
282
|
Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms.
|
J Gastrointest Surg
|
2014
|
0.75
|
|
283
|
Surgical management of neuroendocrine tumors: treatment of localized and metastatic disease.
|
Oncology (Williston Park)
|
2011
|
0.75
|
|
284
|
Multidisciplinary clinic in the management of hepatocellular carcinoma.
|
Ann Surg Oncol
|
2013
|
0.75
|
|
285
|
Propensity score methods: setting the score straight.
|
Arch Surg
|
2011
|
0.75
|
|
286
|
Is there an association between implementation of a medical team training program and surgical mortality?
|
Can J Surg
|
2013
|
0.75
|
|
287
|
Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons.
|
HPB (Oxford)
|
2014
|
0.75
|
|
288
|
Withdrawing medically futile treatment.
|
J Oncol Pract
|
2009
|
0.75
|
|
289
|
Liver metastasis as the initial presentation of adenoid cystic carcinoma.
|
Dig Dis Sci
|
2014
|
0.75
|
|
290
|
What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma?
|
J Gastrointest Surg
|
2015
|
0.75
|
|
291
|
Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.
|
J Am Coll Surg
|
2012
|
0.75
|
|
292
|
Neuroendocrine liver metastasis: transplant as part of multimodality liver-directed therapy.
|
Arch Surg
|
2012
|
0.75
|
|
293
|
Intracavitary balloon brachytherapy for breast cancer: surgical considerations. in regard to Keisch M, Vicini F, Kuske RR, et al., IJROBP 2003;55:289-293.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.75
|
|
294
|
Staging of hepatocellular carcinoma.
|
Hepatology
|
2005
|
0.75
|
|
295
|
Segmental atrophy of the liver: an uncommon and often unrecognized pseudotumor.
|
Dig Dis Sci
|
2014
|
0.75
|
|
296
|
A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborative.
|
J Gastrointest Surg
|
2014
|
0.75
|
|
297
|
Pancreaticoduodenectomy after bariatric surgery: challenges and available techniques for reconstruction.
|
J Gastrointest Surg
|
2013
|
0.75
|
|
298
|
Comparative effectiveness in hepatic malignancies.
|
Cancer Treat Res
|
2015
|
0.75
|
|
299
|
Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.
|
Am Surg
|
2017
|
0.75
|
|
300
|
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.
|
Ann Surg
|
2017
|
0.75
|
|
301
|
Defining Transfusion Triggers and Utilization of Fresh Frozen Plasma and Platelets Among Patients Undergoing Hepatopancreaticobiliary and Colorectal Surgery.
|
Ann Surg
|
2015
|
0.75
|
|
302
|
Can the risk of non-home discharge after resection of gastric adenocarcinoma be predicted: a seven-institution study of the US Gastric Cancer Collaborative.
|
J Gastrointest Surg
|
2014
|
0.75
|
|
303
|
Integrating partial breast irradiation into surgical practice and clinical trials.
|
Surg Clin North Am
|
2007
|
0.75
|
|
304
|
Scientific impact of Association for Academic Surgery and Society of University Surgeons plenary session abstracts increases in the era of the Academic Surgical Congress from 2006 to 2010.
|
J Surg Res
|
2012
|
0.75
|
|
305
|
Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer.
|
Ann Surg
|
2016
|
0.75
|
|
306
|
A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal versus Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population.
|
Am Surg
|
2017
|
0.75
|
|
307
|
Image of the month. Recurrent metastatic HCC.
|
Arch Surg
|
2012
|
0.75
|
|
308
|
Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium.
|
Am Surg
|
2017
|
0.75
|
|
309
|
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer.
|
Oncology (Williston Park)
|
2016
|
0.75
|
|
310
|
Image of the month-quiz case.
|
Arch Surg
|
2012
|
0.75
|
|
311
|
Preoperative biopsy evaluation of chemotherapy-associated liver injuries: looking for a needle in a haystack? Comment on "prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injury".
|
Arch Surg
|
2012
|
0.75
|
|
312
|
ACR Appropriateness Criteria® Resectable Pancreatic Cancer.
|
Am J Clin Oncol
|
2017
|
0.75
|
|
313
|
Consideration of KRAS Mutational Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET Scan, in Patients With Colorectal Liver Metastases.
|
Ann Surg
|
2017
|
0.75
|
|
314
|
Increased complications after appendectomy in patients with cerebral palsy: are special needs patients at risk for disparities in outcomes?
|
Surgery
|
2013
|
0.75
|
|
315
|
Image of the month. Gastrohepatic fistula following TACE for HCC.
|
Arch Surg
|
2009
|
0.75
|
|
316
|
Current Management of Perihilar Cholangiocarcinoma and Future Perspectives.
|
Chirurgia (Bucur)
|
2017
|
0.75
|
|
317
|
Total pancreatectomy for the management of refractory post-gastric bypass hypoglycemia.
|
Dig Dis Sci
|
2014
|
0.75
|
|
318
|
The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
|
Ann Surg
|
2016
|
0.75
|
|
319
|
Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options.
|
Future Oncol
|
2014
|
0.75
|
|
320
|
Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability.
|
Ann Surg
|
2015
|
0.75
|
|
321
|
Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.
|
Pancreas
|
2017
|
0.75
|
|
322
|
Images of the month. Hydatid disease.
|
Am J Gastroenterol
|
2014
|
0.75
|
|
323
|
Ottawa Criteria for Appropriate Transfusions in Hepatectomy: Using the RAND/UCLA Appropriateness Method.
|
Ann Surg
|
2017
|
0.75
|
|
324
|
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis.
|
J Gastrointest Surg
|
2015
|
0.75
|
|
325
|
Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma.
|
J Hepatobiliary Pancreat Surg
|
2006
|
0.75
|
|
326
|
The Role of Neoadjuvant Therapy in Characterizing Indeterminate Lung Lesions in Patients with Resectable Colorectal Liver Metastases.
|
Ann Surg Oncol
|
2015
|
0.75
|
|
327
|
Portal vein encasement complicates resection of Klatskin's tumor.
|
JAAPA
|
2010
|
0.75
|
|
328
|
Age of Transfused Blood Impacts Perioperative Outcomes Among Patients Who Undergo Major Gastrointestinal Surgery.
|
Ann Surg
|
2017
|
0.75
|